pyruvaldehyde has been researched along with glucagon-like peptide 1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, K; Fujioka, H; Ichiyanagi, A; Imaeda, K; Joh, T; Kamiya, Y; Kimura, R; Mizuno, T; Okayama, N; Okouchi, M; Ryuge, F | 1 |
| Asai, K; Imaeda, K; Joh, T; Kato, T; Kimura, R; Okayama, N; Okouchi, M | 1 |
| Hölscher, C; Jalewa, J; Sharma, MK | 1 |
| Chang, TJ; Chang, YC; Chuang, LM; Hsieh, ML; Liu, MW; Tseng, HC | 1 |
| Doi, S; Irifuku, T; Masaki, T; Nagai, T; Nakashima, A; Sasaki, K; Ueno, T | 1 |
| Bugert, P; Busch, S; Dietrich, N; Fleming, T; Hammes, HP; Kaiser, U; Klein, T; Kolibabka, M; Lin, J; Morcos, M; Schlotterer, A | 1 |
6 other study(ies) available for pyruvaldehyde and glucagon-like peptide 1
| Article | Year |
|---|---|
Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway.
Topics: Animals; Apoptosis; Catalytic Domain; Glucagon-Like Peptide 1; Glutamate-Cysteine Ligase; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Phosphatidylinositol 3-Kinases; Protein Kinases; Proto-Oncogene Proteins c-akt; Pyruvaldehyde; Rats; Signal Transduction; TOR Serine-Threonine Kinases | 2009 |
Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis.
Topics: Animals; Apoptosis; Brain Diseases, Metabolic; Cytoprotection; Diabetes Complications; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glucagon-Like Peptide 1; Heparin-binding EGF-like Growth Factor; Intercellular Signaling Peptides and Proteins; Neurons; Neuroprotective Agents; PC12 Cells; Phosphorylation; Protein Kinases; Pyruvaldehyde; Rats; Signal Transduction; Transcriptional Activation; Transforming Growth Factor alpha | 2013 |
Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.
Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Calcium; Caspase 3; Cell Line; Cell Proliferation; Cell Survival; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Immunohistochemistry; Liraglutide; Membrane Potentials; Membrane Proteins; Mitochondrial Proteins; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Oncogene Protein v-akt; Pyruvaldehyde; Receptors, Glucagon; Stress, Physiological | 2014 |
Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Glucagon-Like Peptide 1; Hypoglycemic Agents; Insulin-Secreting Cells; Metformin; Mitochondria; Phosphatidylinositol 3-Kinases; Pyruvaldehyde; Rats; Signal Transduction | 2016 |
Linagliptin Ameliorates Methylglyoxal-Induced Peritoneal Fibrosis in Mice.
Topics: Animals; Biomarkers; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Injections, Intraperitoneal; Linagliptin; Male; Mice; Mice, Inbred C57BL; Peritoneal Fibrosis; Pyruvaldehyde | 2016 |
The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy.
Topics: Animals; Blood Glucose; Caenorhabditis elegans; Diabetic Retinopathy; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hypoglycemic Agents; Linagliptin; Male; Pericytes; Pyruvaldehyde; Rats; Rats, Wistar; Retinal Ganglion Cells | 2016 |